基本信息
views: 102
Career Trajectory
Bio
Bodor’s main research interests include design of drugs with improved therapeutic index, design of new chemical delivery systems, computer-assisted drug design, drug transport and metabolism, and theoretical and mechanistic organic chemistry. He has published more than 500 research articles, holds more than 180 patents, and is on the editorial boards of several international scientific journals. Bodor is the founder and organizer of a biennial series of symposia entitled, The Retrometabolism Based Drug Design and Targeting Conference, which is dedicated to the study of the drug optimization strategies that he has pioneered. The soft steroid Loteprednol Etabonate, he designed, is on the market in the U.S. and other countries. Other drugs he has designed using the retrometabolic concepts are in advanced clinical development.
Research Interests
Papers共 506 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Expert Opinion on Drug Metabolism & Toxicologyno. 3 (2023): 139-148
IUPAC Standards Online (2022)
IUPAC Standards Online (2022)
IUPAC Standards Online (2022)
IUPAC Standards Online (2022)
IUPAC Standards Online (2022)
IUPAC Standards Online (2022)
IUPAC Standards Online (2022)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn